We serve Chemical Name:5-benzyl-1H-pyridazin-6-one CAS:479481-55-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-benzyl-1H-pyridazin-6-one
CAS.NO:479481-55-5
Synonyms:4-BENZYL-3(2H)-PYRIDAZINONE;4-Benzyl-2H-pyridazin-3-one
Molecular Formula:C11H10N2O
Molecular Weight:186.21000
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:45.75000
Exact Mass:186.07900
LogP:1.36070
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 4-BENZYL-3(2H)-PYRIDAZINONE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-Benzyl-2H-pyridazin-3-one physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-Benzyl-2H-pyridazin-3-one Use and application,4-Benzyl-2H-pyridazin-3-one technical grade,usp/ep/jp grade.
Related News: He added that the government raised the travel advice warning to level four, the highest, meaning they’re now advising people not to travel to mainland China. The warning aims to address ��the issue of the human-to-human transmission of the coronavirus.�� 5-benzyl-1H-pyridazin-6-one manufacturer Last year, California became the first state in the country to ban toxic chemicals in cosmetics — including a number of PFAS. Maryland did the same this month, but the laws don’t take effect until 2025, the Post reported. 5-benzyl-1H-pyridazin-6-one supplier This dosage form may also support combination therapy modalities.? To date, over 400 patients have been dosed with the oral formulation of rigosertib in clinical trials.? Combination therapy of oral rigosertib with azacitidine, the standard of care in HR-MDS, has also been studied. Currently, oral rigosertib is being developed as a combination therapy together with azacitidine for patients with higher-risk MDS who require HMA therapy.? 5-benzyl-1H-pyridazin-6-one vendor The program caused the price of some drugs to plunge more than 90% when it was introduced last year in some cities, state news agency Xinhua said. 5-benzyl-1H-pyridazin-6-one factory Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data.
